Multicentric Study Comparing Carcinological and Functional Results of Surgery
Phase 3
- Conditions
- Cancer of the PROSTATE
- Interventions
- Procedure: Radical laparoscopy prostatectomyProcedure: Radical retropubic prostatectomy
- Registration Number
- NCT00502723
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Brief Summary
National multicentric prospective open study, comparing two current surgical methods: laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer.
- Detailed Description
The aim of this study is to show that radical prostatectomy by laparoscopic way could obtain carcinological results not lower than theses with radical retropubic surgery.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 1440
Inclusion Criteria
- Male, old patient of less than 70 years,
- having a prostate cancer proven histologically, requiring a radical prostatectomy.
- Clinical stage T1c and rate of PSA (with 20 ng/ml).
- Osseous scintiscanning and abdomen-pelvic scanner negative.
- Patient informed of the study and its participation.
- Patient affiliated to a social security system.
Read More
Exclusion Criteria
- Contra-indication with the surgery or the anaesthesia.
- Antecedent of prostate resection or adenomectomy.
- Antecedent of inguinal hernia treatment.
- Antecedent of deep venous thrombosis of the lower limbs or pulmonary embolism
- Patient privatized of freedom.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Radical laparoscopy prostatectomy Radical laparoscopy prostatectomy 1 Radical retropubic prostatectomy Radical retropubic prostatectomy
- Primary Outcome Measures
Name Time Method laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer. during the study
- Secondary Outcome Measures
Name Time Method Carcinological (percentage of positive surgical margins, percentage of capsular crossing). after the surgical Functional (urinary continence, sexuality, quality of life) at 2 years per and post operational morbidity during the 36 months economic duration and cost of hospitalization
Trial Locations
- Locations (1)
Groupe Hospitalier Albert Chenevier Henri Mondor
🇫🇷Creteil, France